Radovan Vrhovac
Radovan Vrhovac
Full Professor of Medicine, School of Medicine, University of Zagreb
Potvrđena adresa e-pošte na mef.hr - Početna stranica
Prognostic Significance of the Cell Cycle Inhibitor p27Kip1 in Chronic B-Cell Lymphocytic Leukemia
R Vrhovac, A Delmer, R Tang, JP Marie, R Zittoun, ...
Blood, The Journal of the American Society of Hematology 91 (12), 4694-4700, 1998
The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma
LE Toner, R Vrhovac, EA Smith, J Gardner, M Heaney, M Gonen, ...
Clinical Cancer Research 12 (3), 924-932, 2006
Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious …
D Averbuch, G Tridello, J Hoek, M Mikulska, H Akan, ...
Clinical infectious diseases 65 (11), 1819-1828, 2017
More on prognostic significance of FLT3/ITD size in acute myeloid leukemia (AML)
R Kusec, O Jaksic, S Ostojic, I Kardum-Skelin, R Vrhovac, B Jaksic, ...
Blood 108 (1), 405-406, 2006
Role of angiogenesis in chronic lymphocytic leukemia
T Letilovic, R Vrhovac, S Verstovsek, B Jaksic, A Ferrajoli
Cancer: Interdisciplinary International Journal of the American Cancer …, 2006
Cyclin D1 overexpression allows identification of an aggressive subset of leukemic lymphoproliferative disorder
V Levy, V Ugo, A Delmer, R Tang, S Ramond, JY Perrot, R Vrhovac, ...
Leukemia 13 (9), 1343-1351, 1999
Ruxolitinib for the treatment of myelofibrosis: its clinical potential
A Ostojic, R Vrhovac, S Verstovsek
Therapeutics and Clinical Risk Management 8, 95, 2012
A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia
M Kalac, A Quintás‐Cardama, R Vrhovac, H Kantarjian, S Verstovsek
Cancer 110 (5), 955-964, 2007
Ruxolitinib: a new JAK1/2 inhibitor that offers promising options for treatment of myelofibrosis
A Ostojic, R Vrhovac, S Verstovsek
Future oncology 7 (9), 1035-1043, 2011
Primary gastrointestinal non-Hodgkin lymphoma in adults: clinicopathologic and survival characteristics
D Radić-Krišto, A Planinc-Peraica, S Ostojić, R Vrhovac, I Kardum-Skelin, ...
Collegium antropologicum 34 (2), 413-417, 2010
Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects
H Akan, VP Antia, M Kouba, J Sinko, AD Tănase, R Vrhovac, R Herbrecht
Journal of antimicrobial chemotherapy 68 (suppl_3), iii5-iii16, 2013
Splenomegaly in myelofibrosis—new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors
J Randhawa, A Ostojic, R Vrhovac, E Atallah, S Verstovsek
Journal of hematology & oncology 5 (1), 43, 2012
Drug-induced liver injury associated with Noni (Morinda citrifolia) juice and phenobarbital
A Mrzljak, I Košuta, A Škrtić, T Filipec Kanižaj, R Vrhovac
Case reports in gastroenterology 7 (1), 19-24, 2013
Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation …
R Vrhovac, M Labopin, F Ciceri, J Finke, E Holler, J Tischer, B Lioure, ...
Bone marrow transplantation 51 (2), 186-193, 2016
Diffuse large B-cell lymphoma in patient after treatment of angioimmunoblastic T-cell lymphoma
N Džeko Škugor, Z Perić, R Vrhovac, D Radić-Krišto, I Kardum-Skelin, ...
Collegium antropologicum 34 (1), 241-245, 2010
Influence of additional criteria from a definition of cachexia on its prevalence—good or bad thing?
T Letilovic, R Vrhovac
European journal of clinical nutrition 67 (8), 797-801, 2013
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European …
O Penack, M Marchetti, T Ruutu, M Aljurf, A Bacigalupo, F Bonifazi, ...
The Lancet Haematology 7 (2), e157-e167, 2020
Post-thaw viability of cryopreserved hematopoietic progenitor cell grafts: does it matter?
R Vrhovac, Z Perić, S Jurenec, I Kardum-Skelin, B Jelić-Puškarić, B Jakšić
Collegium antropologicum 34 (1), 163-169, 2010
Drug trials on healthy volunteers in Yugoslavia.
R Vrhovac, I Francetić, K Rotim
International journal of clinical pharmacology, therapy, and toxicology 28 …, 1990
Metachronous gastrointestinal stromal tumor and acute leukemia after liver transplantation for cholangiocellular carcinoma: is there a link
A Mrzljak, I Košuta, A Škrtić, I Kardum-Skelin, R Vrhovac
Case reports in oncology 6 (1), 163-168, 2013
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20